The renin-aldosterone axis in two models of reduced renal mass in the rat

Journal of the American Society of Nephrology

Volumn 9, Issue 1, 1998, Pages 72-76

  Ibrahim, Hassan N ^a   Hostetter, Thomas H ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; POTASSIUM; RENIN;

ADOLESCENT; ALDOSTERONE BLOOD LEVEL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLOMERULOSCLEROSIS; HYPERTENSION; KIDNEY INFARCTION; MALE; NEPHRECTOMY; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEINURIA; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0031975076     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Anderson S, Rennke H, Brenner B: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77: 1993-2000, 1986
2. Lafayette RA, Mayer G, Park SK, Meyer TW: Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 90: 766-771, 1992
3. Rosenberg ME, Smith LJ, Correa-Rotter R, Hostetter TH: The paradox of the renin-angiotensin system in chronic renal disease. Kidney Int 45: 403-410, 1994
4. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329: 1456-1462, 1993
5. Greene E, Kren S, Hostetter TH: Role of aldosterone in the remnant kidney model in the rat. J Clin Invest 98: 1063-1068, 1996
6. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM: Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. Am J Physiol 241: F85-F93, 1981
7. Shimura T, Morrison AB: A progressive glomerulosclerosis occurring in partial five-sixths nephrectomized rats. Am J Pathol 79: 95-106, 1975
8. Purkerson ML, Hoffsten PE, Klahr S: Pathogenesis of the glomerulopathy associated with renal infarction in rats. Kidney Int 9: 407-417, 1976
9. Brenner BM: Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int 23: 647-655. 1983
10. Brenner BM: Nephron adaptation to renal injury or ablation. Am J Physiol 249: F324-F337, 1985
11. Brenner BM, Garcia DL, Anderson S: Glomeruli and blood pressure: Less of one, more of the other? Am J Hypertens 1: 335-347, 1988
12. Gretz N, Waldherr R, Strauch M: The remnant kidney model. In: Experimental and Genetic Rat Models of Chronic Renal Failure, edited by Gretz N, Strauch M, Basel, Switzerland, Karger, 1993, pp 1-28
13. Griffin KA, Picken M, Bidani AK: Method of renal mass reduction is a critical modulator of subsequent injury and hypertension. J Am Soc Nephrol 4: 2023-2031, 1994
14. Griffin KA, Picken M, Bidani AK: Differences in the potential functional and structural mediators of glomerulosclerosis between the infarction and surgical excision models of 5/6 renal mass reduction [Abstract]. J Am Soc Nephrol 7: 1854-1855,1996
15. Koletsky S: Role of salt and renal mass in experimental hypertension. Arch Pathol 68: 11-22, 1959
16. Daniels BS, Hostetter TH: Adverse effects of growth in the glomerular circulation. Am J Physiol 258: F1409-1416, 1990
17. Lax DS, Benstein JA, Tolbert E, Dworkin LD: Effects of salt restriction on renal growth and glomerular injury in rats with remnant kidneys. Kidney Int 41: 1527-1534, 1992
18. Correa-Rotter R, Hostetter TH, Manivel JC, Rosenberg ME: Renin expression in renal ablation. Hypertension 20: 483-490, 1992
19. Cowley AW: Long-term control of arterial blood pressure. Physiol Rev 72: 231-278, 1992
20. Onoyama K, Bravo EL, Tarazi RC: Sodium, extracellular fluid volume, and cardiac output changes in the genesis of mineralocorticoid hypertension in the intact dog. Hypertension 1: 331-336, 1979
21. Pan Y, Young D: Experimental aldosterone hypertension in the dog. Hypertension 4: 279-287, 1982
22. Suzuki H, Shibata H, Murakami M, Sato A, Naito M, Ichihara A, Matsumoto A, Tsujimoto G, Hirasawa A: Modulation of angiotensin II type I receptor MRNA expression in human blood cells: Comparison of platelets and mononuclear leukocytes. Endocr J 42: 15-22, 1995
23. Schiffrin EL, Larviere R, Li JS, Sventek P, Touyz RM: Endothelin I gene expression and vascular hypertrophy in DOCA salt hypertension compared to spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 22[Suppl 1]: 5188-5190, 1995
24. Kageyama Y, Bravo EL: Hypertensive mechanisms associated with centrally administered aldosterone in dogs. Hypertension 11: 750-753, 1988
25. Elise P, Gomez S: What is the role of the central nervous system in mineralocorticoid hypertension? Am J Hypertens 4: 374-381, 1991
26. Dworkin LD, Hostetter TH, Rennke HG, Brenner BM: Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension. J Clin Invest 73: 1448-1461, 1984
27. Wakisaka M, Spiro MJ, Spiro RG: Synthesis of type VI collagen by cultured glomerular cells and comparison of its regulation by glucose and other factors with that of type IV collagen. Diabetes 43: 95-103, 1994
28. Brilla CG, Weber KT: Mineralocorticoid excess, dietary medium and myocardial fibrosis. J Lab Clin Med 120: 893-901, 1992
29. Young M, Fullerton M, Dilley R, Funder J: Mineralocorticoids, hypertension and cardiac fibrosis. J Clin Invest 93: 2578-2583, 1994
30. Rosenberg ME, Correa-Rotter R, Inagami T, Kren SM, Hostetter TH: Glomerular renin synthesis and storage in the remnant kidney. Kidney Int 40: 677-683, 1991
31. Pupilli C, Chevalier RL, Carey RM, Gomez A: Distribution and content of renin and renin mRNA in remnant kidney of adult rat. Am J Physiol 263: F731-F738, 1992
32. Young DB, Smith MJ Jr, Jackson TE, Scott RE: Multiplicative interaction between angiotensin II and K concentration in stimutation of aldosterone. Am J Physiol 247: E328-E335, 1984
33. Pratt JH, Rothrock JK, Dominguez JH: Evidence that angiotensin-II and potassium collaborate to increase cytosolic calcium and stimulate the secretion of aldosterone. Endocrinology 125: 2463-2489, 1989